Company / SG&A Expense
GE HealthCare SG&A Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$4.2B
FY2025
5-year range
$3.6B / $4.3B
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#17 of 158
Health Care
What the data says
GE HealthCare's sg&a expense of $4.2B is higher than 89% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 5 years, ranging from $3.6B in FY2023 to $4.3B in FY2024.
Based on SEC 10-K filings.
$4.2B in FY2025 with a 3-year CAGR of +5.2%. Top quartile in the Health Care sector.
Increased from $3.6B to $4.2B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 158This company $4.2B Sector average $175.9B
▼
-97.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +5.2%, indicating consistent growth.
- In FY2025, sg&a expense decreased 1.0% year-over-year.
- Ranks #17 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- Strong return on equity: 22.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2B | -1.0% |
| FY2024 | $4.3B | +19.8% |
| FY2023 | $3.6B | -1.9% |
| FY2022 | $3.6B | +1.9% |
| FY2021 | $3.6B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026